Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119833814 | 11983381 | 4 | F | 20160110 | 20160914 | 20160201 | 20160928 | EXP | US-ACORDA-ACO_120873_2016 | ACORDA | 38.63 | YR | F | Y | 65.94000 | KG | 20160928 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119833814 | 11983381 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, Q 12 HRS | Y | U | 22250 | 10 | MG | TABLET | Q12H | ||||
| 119833814 | 11983381 | 2 | SS | BACLOFEN. | BACLOFEN | 1 | Oral | 10 MG, TID PRN | U | 0 | 10 | MG | TID | ||||||
| 119833814 | 11983381 | 3 | SS | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | Oral | 20 MG, BID | U | 0 | 20 | MG | BID | ||||||
| 119833814 | 11983381 | 4 | SS | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | U | 0 | |||||||||||
| 119833814 | 11983381 | 5 | C | ARMOUR THYROID | THYROID, PORCINE | 1 | Oral | 30 MG, QD | U | 0 | 30 | MG | QD | ||||||
| 119833814 | 11983381 | 6 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | 100 MG, QD | U | 0 | 100 | MG | QD | ||||||
| 119833814 | 11983381 | 7 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | 0.5 MG, QD PRN | U | 0 | .5 | MG | |||||||
| 119833814 | 11983381 | 8 | C | TOPAMAX | TOPIRAMATE | 1 | Oral | 50 MG, TID | U | 0 | 50 | MG | TID | ||||||
| 119833814 | 11983381 | 9 | C | NUEDEXTA | DEXTROMETHORPHAN HYDROBROMIDEQUINIDINE SULFATE | 1 | Oral | UNK, Q 12 HRS | U | 0 | Q12H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119833814 | 11983381 | 1 | Multiple sclerosis |
| 119833814 | 11983381 | 2 | Multiple sclerosis |
| 119833814 | 11983381 | 3 | Fatigue |
| 119833814 | 11983381 | 4 | Multiple sclerosis |
| 119833814 | 11983381 | 5 | Hypothyroidism |
| 119833814 | 11983381 | 6 | Depression |
| 119833814 | 11983381 | 7 | Anxiety |
| 119833814 | 11983381 | 8 | Migraine |
| 119833814 | 11983381 | 9 | Multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119833814 | 11983381 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119833814 | 11983381 | Contraindicated product administered | |
| 119833814 | 11983381 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119833814 | 11983381 | 1 | 20150415 | 0 |